KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • 07/09/2021

    Devex interview about digital adherence technologies: “We hope that our research will contribute to the WHO policy”

    Over the years, digital technologies have been introduced to improve patients’ adherence to tuberculosis (TB) treatment, but with little research…

    Lees meer
  • 02/09/2021

    Kick off collaboration Obafemi Awolowo University Teaching Hospital and KNCV Tuberculosis Foundation

    We are happy to announce the collaboration between the Obafemi Awolowo University Teaching Hospital (OAUTH) and KNCV Tuberculosis…

    Lees meer
  • 25/08/2021

    Webinar: People-Centred Framework Knowledge Hub

    On September 2, at 2 pm CEST a webinar is held to showcase the People-Centred Framework (PCF) Knowledge Hub. The…

    Lees meer
  • 20/08/2021

    New partnership between GC Labs and KNCV Tuberculosis Foundation to strengthen tuberculosis treatment safety monitoring

    GC Labs and KNCV Tuberculosis Foundation (KNCV) will present their newly formed alliance during an…

    Lees meer
  • 10/08/2021

    Publication: SOS stool method can be rolled out to Xpert sites, for a child-friendlier tuberculosis diagnosis closer to point of care

    This study, conducted by KNCV Tuberculosis Foundation, shows that a simple stool processing method can detect Mycobacterium tuberculosis and resistance…

    Lees meer
  • 04/08/2021

    Research begins into new digital tools to support patients and healthcare workers through tuberculosis treatment

    A large global study which aims to determine if digital adherence technologies can provide more patient-friendly approaches to improve tuberculosis…

    Lees meer
  • 19/07/2021

    Publication: Results of the acceptability & feasibility study of the BPaL regimen

    A study, conducted by KNCV Tuberculosis Foundation and TB Alliance, shows that the adoption of BPal…

    Lees meer
  • 15/07/2021

    New Trial Results Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB Can Be Maintained with Reduced Dosing of Linezolid

    TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure…

    Lees meer
  • 15/07/2021

    Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development

    15 July 2021, The Hague. To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions…

    Lees meer
  • 18/06/2021

    Welcome Dr. Harsh Vardhan, India’s Minister of Health, as new Chair of Stop TB Partnership

    KNCV Tuberculosis Foundation welcomes His Excellency Dr. Harsh Vardhan as the new chair of the Stop TB Partnership Board. We are confident that…

    Lees meer
  •  KNCV Publications

    Overview of KNCV Publications by year Publications 2024 Nwokoye N, Odume B,…

    Lees meer
  • 21/05/2021

    Appointments Board of Trustees

    May 11, 2021 the KNCV Members Association appointed Tjipke Bergsma and René Stumpel to the Board of Trustees and re-appointed…

    Lees meer
  • 18/05/2021

    The first TB patient in Nigeria to be treated with the BPaL regimen

    Ruth Iliya, who was first diagnosed in January 2021 is the first TB patient in Nigeria to be treated with…

    Lees meer
  • 18/05/2021

    New hope for drug resistant tuberculosis (TB) patients in Nigeria

    Nigeria is the first country in West Africa to provide people with tuberculosis (TB) access to the groundbreaking new BPaL…

    Lees meer
  • 12/05/2021

    Directory of TB vaccine clinical trial sites

    There are approximately 14 vaccine candidates for tuberculosis (TB). Over the upcoming 10 years these need to be tested in…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.